Category: Include on Menu

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) has entered into two separate agreements with Pfizer Inc. (NYSE:PFE) that will see the companies collaborate on T-cell receptor (TCR) research to support drug discovery and development. The first deal focuses on rheumatoid arthritis, with Adaptive deploying its immune medicine platform to identify T-cell receptors linked to disease activity. Using Pfizer’s…

Shares of FibroGen, Inc. (NASDAQ:FGEN) climbed about 3% on Monday after the company said its drug candidate roxadustat has been granted Orphan Drug Designation by the U.S. Food and Drug Administration for the treatment of myelodysplastic syndromes (MDS). The designation was awarded by the FDA’s Office of Orphan Products Development and comes with several potential…

Kyverna Therapeutics (NASDAQ:KYTX) shares climbed 14% on Monday after the company reported encouraging topline outcomes from its registrational Phase 2 KYSA-8 study evaluating mivocabtagene autoleucel (miv-cel) in patients with stiff person syndrome (SPS). The clinical-stage biotech said the CAR T-cell therapy delivered statistically significant benefits across all primary and secondary endpoints. Patients treated with miv-cel…

Milestone Pharmaceuticals (NASDAQ:MIST) shares jumped roughly 35% after the U.S. Food and Drug Administration approved CARDAMYST, the first nasal spray that patients can self-administer to treat paroxysmal supraventricular tachycardia (PSVT). The decision introduces the first new treatment option in more than three decades for the estimated 2 million people in the U.S. affected by PSVT,…

Immunome (NASDAQ:IMNM) shares soared about 30% after the biotech group reported encouraging topline findings from its Phase 3 RINGSIDE study evaluating varegacestat in patients with desmoid tumors. The pivotal trial achieved its primary endpoint, showing a statistically meaningful improvement in progression-free survival versus placebo. Results indicated an 84% reduction in the risk of disease progression…

Shares in ServiceNow (NYSE:NOW) moved lower in pre-market trading on Monday after reports emerged that the company is holding advanced discussions to buy cybersecurity firm Armis in a deal that could be valued at as much as $7 billion. According to a Bloomberg News report citing people familiar with the situation, an announcement could come…

In this interview, Craig Marshall, head of investor relations at bp (NYSE:BP), provides investors with a comprehensive update on the company’s strategic transformation and operational momentum. Following bp’s February 2025 strategy update, Craig addresses the disciplined capital reallocation, with oil and gas investment up 20% and transition spending down 70%. He also outlines management’s ambitious targets…

Google, part of Alphabet (NASDAQ:GOOGL), has reached an agreement to source solar energy in Malaysia, advancing its strategy to power global operations with clean electricity, according to a Bloomberg report published Monday. The deal involves Google purchasing power from a 30-megawatt solar facility in the state of Kedah. The project is being developed by a…

iRobot (NASDAQ:IRBT), the company behind the Roomba line of robotic vacuum cleaners, has filed for Chapter 11 bankruptcy protection and reached a restructuring agreement with its secured lender and key manufacturing partners, Shenzhen PICEA Robotics and Santrum Hong Kong. As part of the deal, Picea is set to acquire iRobot through a court-supervised transaction. The…

Futures linked to the main U.S. equity benchmarks were modestly higher, with investors preparing for a week packed with potential market-moving events. The agenda includes multiple interest rate decisions from central banks around the world, alongside the release of U.S. economic data that had been postponed due to a prolonged federal government shutdown. Elsewhere, renewed…